Source: Eur Respir J 2007; 29: 624-632
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Bucki R., Byfield F. J., Janmey P. A.. Release of the antimicrobial peptide LL-37 from DNA/F-actin bundles in cystic fibrosis sputum. Eur Respir J 2007; 29: 624-632

Member's Comments

No comment yet.

Related content which might interest you: SerpinB1 in cystic fibrosis airway fluids: quantity, molecular form and mechanism of elastase inhibition Source: Eur Respir J 2011; 37: 1083-1090 Year: 2011 Inhaled heparin in cystic fibrosis Source: Eur Respir J 2006; 27: 354-358 Year: 2006 The antimicrobial peptide CRAMP protects against emphysema Source: Annual Congress 2012 - Cell culture and animal models of lung disease Year: 2012 α1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients Source: Eur Respir J 2007; 29: 240-250 Year: 2007 Anti-inflammatory cytokines in cystic fibrosis lung disease Source: Eur Respir J 2006; 28: 581-587 Year: 2006 Inflammation in cystic fibrosis airways: relationship to increased bacterial adherence Source: Eur Respir J 2001; 17: 27-35 Year: 2001 Recombinant human DNase nebulisation in children with cystic fibrosis: before bedtime or after waking up? Source: Eur Respir J 2007; 30: 763-768 Year: 2007 Characterization of cystic fibrosis airway epithelium in vitro Source: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle Year: 2005 The chemokine decoy PA401 decreases interleukin-8 and chemotactic activity of cystic fibrosis airway samples Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science Year: 2013 Development of secretory leukocyte protease inhibitor (SLPI) variants resistant to degradation by neutrophil elastase Source: International Congress 2014 – New studies into pulmonary proteases and antiproteases Year: 2014 Inhibition of airway proteases in cystic fibrosis lung disease Source: Eur Respir J 2008; 32: 783-795 Year: 2008 Fluticasone reduces IL-6 and IL-8 production of cystic fibrosis bronchial epithelial cells via IKK-β kinase pathway Source: Eur Respir J 2003; 21: 574-581 Year: 2003 The role of matrix metalloproteinases in cystic fibrosis lung disease Source: Eur Respir J 2011; 38: 721-727 Year: 2011 The human cathelicidin LL37 and mitochondrial DAMPs induce airway inflammation in epithelial cells and mice Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects Year: 2015 Eosinophil cationic protein stimulates TGF-β1 release by human lung fibroblasts Source: Annual Congress 2005 - Inflammation and remodelling in allergy and asthma Year: 2005 Critical role of cytosolic phospholipase A2? in bronchial mucus hypersecretion in CFTR-deficient mice Source: Eur Respir J 2010; 36: 1120-1130 Year: 2010 Prevalence and clinical significance of auto-antibodies in adults with cystic fibrosis Source: Eur Respir J 2009; 34: 1079-1085 Year: 2009 Dysregulation of the expression and activity of antimicrobial peptides in COPD and cystic fibrosis Source: International Congress 2018 – Antimicrobial host defence and innate immunity in the lung Year: 2018 Ambroxol suppresses influenza-virus proliferation in the mouse airway by increasing antiviral factor levels Source: Eur Respir J 2002; 19: 952-958 Year: 2002 Expression of HCLCA1 in cystic fibrosis lungs is associated with mucus overproduction Source: Eur Respir J 2004; 23: 846-850 Year: 2004